Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
797天前
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
1064天前
European Economic News Preview: German Ifo Business Confidence Due
Business confidence survey results from Germany and private sector credit from the euro area are the top economic news due on Monday. At 3.00 am ET, household lending from Sweden and monetary aggregates from Norway are due.
RTTNews
|
1小時38分鐘前
European Shares Seen Higher As US, China Agree Framework Of Trade Deal
European stocks are likely to open higher on Monday after the U.S. and China hailed progress in trade talks in Malaysia.
RTTNews
|
1小時39分鐘前
Yen Falls Amid Fiscal Worries
The Japanese yen weakened against other major currencies in the Asian session on Monday, as fiscal concerns replaced the Bank of Japan's (BoJ) rate hike expectations.
RTTNews
|
2小時19分鐘前
Commodity Currencies Rise Amid Risk-on Mood
The commodity currencies such as Australia, the New Zealand and the Canadian dollars strengthened against other major currencies in the Asian session on Monday amid increased risk-on mood, as traders remain optimistic the US Fed will cut interest rate by another 50 bps by year-end on easing trade tensions between the U.S. and China and cooler-than-expected US consumer price inflation data. They now look ahead to the Fed's monetary policy announcement later in the week.
RTTNews
|
2小時27分鐘前
Yen Falls Against Majors
The Japanese yen weakened against other major currencies in the Asian session on Monday.
RTTNews
|
2小時40分鐘前
Canadian Dollar Climbs Against Most Majors
The Canadian dollar strengthened against most major currencies in the Asian session on Monday.
RTTNews
|
2小時47分鐘前
